Categories Earnings, Finance, Other Industries

Lockheed Martin continues strong run in Q2, raises guidance

Defense company Lockheed Martin (NYSE: LMT) on Tuesday reported second-quarter earnings that surpassed Wall Street expectations. The company reported Q2 earnings of $5 per share including certain severance charges of $96 million, which was way ahead of the street projection of $4.77 per share.

Revenue grew 7% to $14.4 billion, surpassing the target of $14.2 billion set by analysts. The company reported revenue growth in all four business units.

lockheed martin  reported Q2 earnings of $5 per share  which was way ahead of the street projection of $4.77 per share.

The biggest segment, Aeronautics grew 4.3%, while Missiles and Fire Control delivered the highest growth rate of 15%. Rotary and Mission Systems revenues improved 5.6% and Space operations saw revenues jump 11%.

LMT shares gained 1.6% following the announcement. The stock has gained 35% in the year-to-date period.

CEO Lockheed Martin said, “The corporation achieved another quarter of strong operational and financial results across all four of our businesses, which allowed us to grow our backlog to a new record level and to increase our financial outlook for 2019.”

READ: Virgin Galactic vs. Blue Origin: The race to suborbital space tourism

Guidance raised

Buoyed by the better-than-expected results, Biogen raised its full-year revenue guidance to $58,250 billion – $59,750 billion, compared to the earlier guidance range of $56,750 billion – $58,250 billion.

EPS is expected to be between $20.85 and $21.15, an increase from the prior guidance range of $20.05 – $20.35.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top